Literature DB >> 12667236

Age-specific seroprevalence of Human Herpesvirus 8 in Mediterranean regions.

P Cattani1, F Cerimele, D Porta, R Graffeo, S Ranno, S Marchetti, R Ricci, N Capodicasa, L Fuga, R Amico, G Cherchi, M Gazzilli, S Zanetti, G Fadda.   

Abstract

OBJECTIVE: Human herpesvirus 8 (HHV8) is believed to be transmitted mainly by sexual contact; epidemiological data from Africa show, however, that non-sexual transmission routes may also play an important role. To evaluate better the distribution of HHV8 infection in the Mediterranean area, we performed an age-specific seroprevalence study.
METHODS: Sera were collected from subjects from different geographical areas. The sera were analyzed by immunofluorescence assay (IFA) and enzyme-linked immunosorbent assay (ELISA). A total of 1083 patients were studied, 667 patients from various regions of Italy and 416 from Albania. The patients were stratified into six age groups. Multivariate logistic regression was used to evaluate associations between HHV8 and demographic data.
RESULTS: An overall seropositivity rate of 17.6% was observed. The highest rate was observed in Sardinia (25.0%) and the lowest was found in Albania (13.9%). The prevalence rate increased linearly with age, from 9.7% in patients belonging to the 0-14 years age group to 26.3% for patients more than 59 years old. Seropositivity for HHV8 was significantly associated with membership of the 59 years-plus age group. Rates of seropositivity were significantly higher in patients from central southern Italy (OR = 1.7) and Sardinia (OR = 1.8) than in patients from Albania.
CONCLUSIONS: The data suggest that HHV8 is widespread in the Mediterranean area, including regions like Albania that have not been previously investigated. The statistically significant association between HHV8 seropositivitity and increasing age suggests that non-sexual transmission routes may be involved in the spread of the virus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667236     DOI: 10.1046/j.1469-0691.2003.00490.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  10 in total

1.  Association of Kaposi’s sarcoma-associated herpesvirus (KSHV) with bladder cancer in Croatian patients.

Authors:  Martina Paradžik; Viljemka Bučević-Popović; Marijan Šitum; Crystal J Jaing; Marina Degoricija; Kevin S McLoughlin; Said I Ismail; Volga Punda-Polić; Janoš Terzić
Journal:  Tumour Biol       Date:  2014-01

2.  Inhibitory KIR2DL2 receptor and HHV-8 in classic or endemic Kaposi sarcoma.

Authors:  Daria Bortolotti; Monica Corazza; Antonella Rotola; Dario Bencivelli; Giovanna Schiuma; Elisabetta Danese; Sabrina Rizzo; Silvia Beltrami; Roberta Rizzo; Alessandro Borghi
Journal:  Clin Exp Med       Date:  2022-02-15       Impact factor: 3.984

Review 3.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

4.  Human herpesvirus 8 seroprevalence among Tobago women and the role of sexual lifestyle behavior.

Authors:  Alicia C McDonald; Camille C Ragin; Frank J Jenkins; Joel Weissfeld; John Wilson; Victor W Wheeler; Jaquie B Wilson; Clareann H Bunker; Emanuela Taioli
Journal:  J Med Virol       Date:  2009-02       Impact factor: 2.327

5.  A case-cohort study of human herpesvirus 8 seropositivity and incident prostate cancer in Tobago.

Authors:  Alicia C McDonald; Frank J Jenkins; Clareann H Bunker; John W Wilson; Alan L Patrick; Joel L Weissfeld
Journal:  Infect Agent Cancer       Date:  2011-12-07       Impact factor: 2.965

6.  Treatment of Disseminated Classic Type of Kaposi's Sarcoma with Paclitaxel.

Authors:  Soo Yeon Kim; Dae Hoon Kim; Hyo Jin Lee; Young Joon Seo; Jeung Hoon Lee; Young Lee
Journal:  Ann Dermatol       Date:  2011-11-03       Impact factor: 1.444

7.  The seroprevalence of Kaposi's sarcoma associated herpes virus and human herpes virus-6 in pediatric patients with cancer and healthy children in a Turkish pediatric oncology center.

Authors:  Nurdan Tacyildiz; Handan Ugur Dincaslan; Halil Ozdemir; Gulsan Yavuz; Emel Unal; Aydan Ikinciogullari; Figen Dogu; Deniz Guloglu; Emine Suskan; Kenan Kose
Journal:  Indian J Med Paediatr Oncol       Date:  2014-07

8.  Potential Association between Kaposi Sarcoma and Gout: An Exploratory Observational Study.

Authors:  Assaf Moore; Idit Peretz; Lilach Yosef; Daniel A Goldstein; Hadar Goldvaser; Suzanna Horn; Yonatan Edel; Alona Zer
Journal:  Sarcoma       Date:  2020-12-01

9.  Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995-2002).

Authors:  V Ascoli; G Minelli; M Kanieff; R Crialesi; L Frova; S Conti
Journal:  Br J Cancer       Date:  2009-08-25       Impact factor: 7.640

Review 10.  The Vaginal Virome-Balancing Female Genital Tract Bacteriome, Mucosal Immunity, and Sexual and Reproductive Health Outcomes?

Authors:  Anna-Ursula Happel; Arvind Varsani; Christina Balle; Jo-Ann Passmore; Heather Jaspan
Journal:  Viruses       Date:  2020-07-30       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.